Clinicopathological Profile of Head and Neck Cancers in Army Hospital of Nepal

Sponsor

Tribhuvan University, Nepal (Other)

Overall Status

Completed

CT.gov ID

NCT06152055

Collaborator

(none)

Enrollment

Location

Actual Duration (Months)

6.4

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

This is a observational study conducted at the department of Ear ,Nose and Throat -Head and Neck Surgery (ENT-HNS) of Shree Birendra Hospital ,a tertiary health care centre of Nepal. Head and Neck cancers are the sixth most common cancer in the world. Data was collected from the medical records of Head and Neck Cancer patients who underwent treatment between May 2022 to April 2023.The main aim of the study was to know about the common cancers of head and neck region and their distribution according to the site. Also to know the stage of the presentation with treatment modalities in the tertiary health care centre of Nepal.

Condition or Disease	Intervention/Treatment	Phase
Head and Neck Cancer

Detailed Description

This is a retrospective study to know the prevalence of Head and Neck Cancer at the department of ENT- Head and Neck Surgery of Shree Birendra Hospital ,a tertiary health care centre of Nepal .Head and neck cancers are malignant neoplasms that develops in oral cavity, nasal cavities, paranasal sinuses,nasopharynx, oropharynx, hypopharynx, ear, scalp, salivary gland and neck,Data was collected from the medical records of Head and Neck Cancer patients who underwent treatment between May 2022 to April 2023. Data considered of demographic details of age, sex, diagnosis, subsite specific Head and Neck Cancers, treatment modality and histopathology. The data was analyzed using Stastical Package for Social Sciences (SPSS) version 22. Pearson's chi-square test was applied and p value <0.05 was considered statistically significant.

Study Design

Study Type:

Observational

Actual Enrollment :

76 participants

Observational Model:

Cohort

Time Perspective:

Retrospective

Official Title:

Clinicopathological Profile of Head and Neck Cancers in Army Hospital of Nepal - A Retrospective Study

Actual Study Start Date :

May 1, 2022

Actual Primary Completion Date :

Apr 30, 2023

Actual Study Completion Date :

Apr 30, 2023

Outcome Measures

Primary Outcome Measures

Age - wise Distribution of Head and Neck Cancers (HNCs) [1 year]
Age - wise Distribution of Head and Neck Cancer
: Distribution of HNCs according to subsite [1 year]
Distribution of Head and Neck Cancers according to the subsite
Histopathology of HNCs [1 year]
Histopathology of Head and Neck Cancer
Tumor, Nodes, Metastasis (TNM) staging of HNC [1 year]
Staging at presentation of Head and Neck Cancer
Treatment provided to HNC patients [1 year]
Treatment Modalities of Head and Neck Cancer

Eligibility Criteria

Criteria

Ages Eligible for Study:

17 Years to 84 Years

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Inclusion Criteria:

All histologically proven cases of head and neck region.

Exclusion Criteria:

Patient's record with incomplete data.

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Shree Birendra Hospital	Kathmandu		Nepal	977

Sponsors and Collaborators

Tribhuvan University, Nepal

Investigators

Principal Investigator: Reeba Karki, MS, Shree Birendra Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

Chin D, Boyle GM, Porceddu S, Theile DR, Parsons PG, Coman WB. Head and neck cancer: past, present and future. Expert Rev Anticancer Ther. 2006 Jul;6(7):1111-8. doi: 10.1586/14737140.6.7.1111.

Responsible Party:

Anupama Marasini, Intern Doctor, Tribhuvan University, Nepal

ClinicalTrials.gov Identifier:

NCT06152055

Other Study ID Numbers:

First Posted:

Nov 30, 2023

Last Update Posted:

Nov 30, 2023

Last Verified:

Nov 1, 2023

Individual Participant Data (IPD) Sharing Statement:

Plan to Share IPD:

Studies a U.S. FDA-regulated Drug Product:

Studies a U.S. FDA-regulated Device Product:

Keywords provided by Anupama Marasini, Intern Doctor, Tribhuvan University, Nepal

Head and Neck Cancer

Radiotherapy

Chemotherapy

Additional relevant MeSH terms:

Head and Neck Neoplasms

Study Results

No Results Posted as of Nov 30, 2023